Experience with long-term rituximab use in a multiple sclerosis clinic
{{output}}
Background: Rituximab is a monoclonal antibody directed at CD20 positive B-lymphocytes and a potential therapeutic option in the treatment of multiple sclerosis. The safety of recurrent dosing is not established. ... ...
